Shanghai Xinyi Tianping Pharmaceutical

Shanghai Xinyi Tianping Pharmaceutical Co., Ltd., a subsidiary of Shanghai Pharmaceuticals Holding Co., Ltd. (SPH), is a prominent Chinese pharmaceutical manufacturer specializing in solid dosage forms. Founded in 1939 and headquartered in Shanghai's Minhang District, the company operates as a key production base for the Sine (Xinyi) brand. Its product portfolio covers a wide range of therapeutic areas, including the nervous system, cardiovascular health, digestive and metabolic diseases, and endocrinology. Notable products include Zopiclone for insomnia, Sulfasalazine for inflammatory bowel disease, and various hormonal therapies. The company is actively involved in the consistency evaluation of generic drugs and maintains international quality standards, including UK MHRA cGMP certification. It focuses on the development of high-end generics and improved formulations to serve both domestic and international markets.